Видео ютуба по тегу Nct03887455

Time saved in Alzheimer’s disease in Phase III trial of donanemab
Time saved in Alzheimer’s disease in Phase III trial of donanemab
Major ongoing clinical trials in AD: aducanumab, donanemab & lecanemab
Major ongoing clinical trials in AD: aducanumab, donanemab & lecanemab
Lecanemab: drawbacks to consider
Lecanemab: drawbacks to consider
The development of lecanemab & rationale behind its unique binding profile
The development of lecanemab & rationale behind its unique binding profile
FDA approval of lecanemab: what does the data tell us about the amyloid hypothesis?
FDA approval of lecanemab: what does the data tell us about the amyloid hypothesis?
3D Scalable QCNNs for Image Classification, and MRI PET for AD Drug Clinical Trials
3D Scalable QCNNs for Image Classification, and MRI PET for AD Drug Clinical Trials
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Клинические испытания для пожилых людей 2025 года: как принять участие и что нужно знать
Клинические испытания для пожилых людей 2025 года: как принять участие и что нужно знать
The potential of lecanemab for the treatment of early Alzheimer’s disease
The potential of lecanemab for the treatment of early Alzheimer’s disease
Lecanemab for the treatment of early Alzheimer’s disease: the story so far
Lecanemab for the treatment of early Alzheimer’s disease: the story so far
Lecanemab vs aducanumab
Lecanemab vs aducanumab
Time saved with Alzheimer’s disease therapeutics
Time saved with Alzheimer’s disease therapeutics
The power of composite tests to track Alzheimer’s disease progression
The power of composite tests to track Alzheimer’s disease progression
Прорыв в лечении болезни Альцгеймера 2025 года: новый препарат, способный замедлить ухудшение памяти
Прорыв в лечении болезни Альцгеймера 2025 года: новый препарат, способный замедлить ухудшение памяти
Lecanemab and what this means for the future treatment of Alzheimer’s disease
Lecanemab and what this means for the future treatment of Alzheimer’s disease
Lecanemab: a review
Lecanemab: a review
The development of lecanemab for the treatment of early Alzheimer’s disease
The development of lecanemab for the treatment of early Alzheimer’s disease
【レカネマブ迅速承認】アルツハイマー病治療の期待と課題を検証──エーザイ×バイオジェンの抗体薬を中立に解説【認知症・医療ニュース】#レカネマブ #アルツハイマー病 #ステラチャンネル
【レカネマブ迅速承認】アルツハイマー病治療の期待と課題を検証──エーザイ×バイオジェンの抗体薬を中立に解説【認知症・医療ニュース】#レカネマブ #アルツハイマー病 #ステラチャンネル
Ошибка #2 Запись на тренировки 89166012244
Ошибка #2 Запись на тренировки 89166012244